Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy
breast cancer
1 other identifier
interventional
60
1 country
1
Brief Summary
Breast cancer is the most common malignant tumor among women. Side effects from initial chemotherapy include sleep disorders, anxiety, depression, and reduced quality of life. Mental health distress is also a major issue in cancer care. This study integrates mobile health information with a nurse-led communication support plan, aiming to improve patients' physical and mental outcomes during chemotherapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2024
CompletedStudy Start
First participant enrolled
November 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedApril 29, 2025
April 1, 2025
6 months
October 4, 2024
April 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Effects of a nursing-led communication support program using mobile health information on physical and mental status in breast cancer patients undergoing concurrent chemotherapy: a randomized controlled trial
Used the Quality of life questionnaire test
1 year
Study Arms (2)
nursing-led communication
EXPERIMENTALnursing-led communication support
Nursing routine treatment
PLACEBO COMPARATORNursing routine treatment
Interventions
nursing-led communication support program using mobile health information
Eligibility Criteria
You may qualify if:
- breast cancer initial chemotherapy
You may not qualify if:
- Patients whose cancer has recurred without undergoing the first course of chemotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tri-Service General Hospital
Taipei, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Student
Study Record Dates
First Submitted
October 4, 2024
First Posted
April 29, 2025
Study Start
November 1, 2024
Primary Completion
May 1, 2025
Study Completion
May 1, 2025
Last Updated
April 29, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share